Institution
Hamad Medical Corporation
Also known as: HMC
- 9running trials
- 2closed trials
- 18,898publications (OpenAlex)
Running trials
Not yet recruiting
Qatar Cardiometabolic Retrospective Cohort-Analysis Using Artificial Intelligence
Recruiting
Not yet recruiting
Recruiting
Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure
Recruiting
Recruiting
Deprescribing Intervention for Patients With Chronic Kidney Disease
Enrolling by invitation
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Coronary artery disease2 recruiting
- Brain aneurysm1 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Stroke1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Registry name variants (1)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Hamad Medical Corporation
Doha, 3050
11 trials
Conditions
Diseases this institution publishes on or runs trials for.
- Deep vein thrombosis and pulmonary embolism27 works · 0 trials
- Hypothyroidism21 works · 0 trials
- Thalassaemia16 works · 0 trials
- Gestational diabetes15 works · 0 trials
- Chronic myeloid leukaemia13 works · 0 trials
- Myeloproliferative neoplasms12 works · 0 trials
- Cushing's syndrome9 works · 0 trials
- Chronic lymphocytic leukaemia9 works · 0 trials
- Coeliac disease8 works · 0 trials
- Sarcoidosis8 works · 0 trials
- Immune thrombocytopenia (ITP)7 works · 0 trials
- Hyperparathyroidism7 works · 0 trials
- Graves' disease6 works · 0 trials
- Iron deficiency anaemia6 works · 0 trials
- Diabetic foot ulcer6 works · 0 trials
- Haemophagocytic lymphohistiocytosis5 works · 0 trials
- Chronic spontaneous urticaria5 works · 0 trials
- Keratoconus4 works · 0 trials
- Optic neuritis4 works · 0 trials
Institution data: ROR 02zwb6n98 (CC0-1.0)Updated 15 Nov 2026